A lot of women come to my clinic complaining that they can’t seem to lose weight, no matter what they try. They might have acne that they haven’t experienced since puberty and notice changes in their hair growth as well. One of the diagnoses that I consider in this case is PCOS. It’s important to explore other possibilities in addition, in order to not only seek a correct diagnosis, but get to the root cause of the hormonal imbalances.
Keep reading to learn:
Polycystic ovary syndrome (PCOS) is a group of symptoms related to high levels of male hormones that are known as androgens. Hyperandrogenism, or high levels of androgens in women, cause PCOS symptoms including the stimulation of hair growth, acne and male pattern baldness. They affect libido and weight. These high levels of male hormones – produced in the adrenal glands, ovaries and fat cells - are thought to prevent the ovaries from making eggs and producing hormones the way they normally would. Most women with hyperandrogenism have PCOS.
There are two different “types” of hyperandrogenism: clinical and biochemical. Either of these can qualify as PCOS. Clinical is visible signs or symptoms indicating androgen production is high, and that can be seen without testing. Biochemical is when labs show high levels of androgens in the blood. It is possible to have clinical signs of hyperandrogenism and for all blood work to come back normal. It is also possible to have labs indicate excess androgens but there be little to no clinical signs.
The most commonly used diagnostic criteria for PCOS is the Rotterdam criteria. Which indicates that either biochemical or clinical signs of hyperandrogenism qualify. For example, let’s say you have facial hair or male pattern baldness. These are clinical signs of hyperandrogenism. You do not need to have elevated labs to quality for the diagnosis of PCOS. Secondly, according to the Rotterdam criteria, you don’t have to have elevated androgens to be diagnosed with PCOS.
Congenital adrenal hyperplasia (CAH) is an inherited disease that results in abnormal functioning of the adrenal glands. Men and women with CAH are missing a vital enzyme that impairs production and regulation of certain hormones. One group of hormones potentially affected are androgens.
Most people born with CAH are diagnosed when they are young, but there is a milder variation of the disease and doesn’t produce obvious symptoms until later in life. This is sometimes known as late-onset CAH or non-classic CAH. The symptoms of non-classic CAH can be very similar to PCOS. Before your doctor can diagnose you with PCOS, non-classic CAH should be ruled out first.
Cushing’s disease is another syndrome that can lead to symptoms similar to PCOS. Cushing’s disease occurs when the body is exposed to high levels of cortisol over an extended period of time. This can happen due to long-term oral steroid use, or it can also occur if the body itself creates the excess cortisol. You should be checked for this, if only to rule it out.
Cushing’s syndrome may be caused by a non-cancerous tumor on the pituitary gland or adrenal gland. This growth may produce abnormally high levels of an androgen hormone, adrenocorticotropic hormone (ACTH). The excess androgens can be mistaken for PCOS. This is why Cushing’s disease must also be ruled out first.
Let me explain the hormone piece in greater detail.
Androgens are precursors (can turn into) to estrogens via what’s known as the steroidogenic pathway. Because of this, excess androgens can be one reason behind estrogen dominance, a condition characterized by a high estrogen to progesterone ratio in the body. Symptoms of estrogen dominance often go hand-in-hand with PCOS and cause symptoms including irritability, sore breasts, water retention, fatigue, PMS, hair loss, infertility and others. Note that lack of ovulation is part of the reason for estrogen dominance. This is because the levels of estrogen remain continuously high, and there is insufficient progesterone to counter these high levels.
What causes PCOS? Causes are thought to be both genetic and environmental. PCOS can even be caused from exposure to androgens and toxins invitro (in the womb before birth). That is different than environmental exposures later in life.
There are many thoughts about why this happens and I’ve cited some interesting resources below for further reading. We’ve talked a little about the relationship with estrogen and there are associations with other female hormones also. One example is gonadotropin-releasing hormone, a hormone in the brain, which can have downstream effects on luteinizing and follicle stimulating hormones, which regulate the female cycle. When these hormones are imbalanced, it affects sex hormones and contributes to symptoms.
PCOS has close associations with diabetes, insulin resistance, metabolic syndrome, and thyroid disease. Additionally, it appears to be interwoven with many factors in the body and, well, it is very complex! The complexity of hormones is one reason that a functional medicine provider is invaluable for helping with the detective work required to uncover what is going on in your unique body.
These are the tests that I recommend when someone presents with symptoms of hyperandrogenism and PCOS:
Testing to rule out: Cushing’s disease, pituitary tumors, thyroid nodules, androgen producing adrenal or ovarian neoplasms, hyperprolactinemia, premature ovarian failure, and congenital adrenal hyperplasia. Why? There are many times that someone is diagnosed with PCOS, when in fact it is not the case. Although PCOS might be the most common diagnosis for a set of symptoms, it is important to rule out other possibilities in order to provide you with the best treatment plan so you can be your healthiest.
At The Fork, we try to work within a patients budget for testing and prioritize testing as such. Sometimes we test and sometimes we treat, and sometimes we do both.
So, what can be done? There are many possible interventions for PCOS to both help heal the root cause and to address the underlying factors that contributed to this syndrome in the first place. Often, I work with both lifestyle factors as well as medical approaches to create a personalized approach for each woman.
Conventional treatment often involves birth control pills and/or metformin (a diabetes medication); however, I believe it’s not in the patient’s best interest to do this and call it a day. I believe it is safest to start with simple interventions that have the least side effects. Then if necessary, we can implement more aggressive measures. It’s a slow process of fine-tuning what you need.
Here are some strategies I use in my clinic:
Some have tried taking pregnenolone, which is a steroid hormone precursor for progesterone. But the problem with any kind of hormone replacement therapies or hormone precursors, such as pregnenolone, is that they are not guaranteed to convert into the hormones your body actually needs. For instance, they can be converted into estrogen downstream and lead to (increased) estrogen dominance as a result of sub-optimal hormone metabolism. Genetic single nucleotide polymorphisms (SNP’s) may also play a role due to effects on enzymes that influence hormone metabolism.
It is complex so it’s important to monitor hormone levels continuously. It is equally as important to know what your body is metabolizing those hormones into. In other words, what your body is making with them. We can tell this by testing hormone metabolites in the urine. In order to know and understand how to best target treatment it is necessary to know where the true issue lies.
There is a lot that can be done to support a woman with PCOS. The first step is to uncover if it truly is a PCOS diagnosis and what else is going on behind the scenes that is contributing to symptoms and hormone imbalance. I have a lot of functional medicine tools in my toolkit that are integrative and things you can start doing to provide yourself relief today. I talk about many dietary, lifestyle and supplement approaches in Part 2 (link) of this PCOS series.
PCOS can be a very frustrating condition that feels hopeless sometimes. Having someone in your corner who will not give up on you means so much! Call today to schedule your appointment with me, Chyrl, at The Fork Functional Medicine.
Bani Mohammad, M., & Majdi Seghinsara, A. (2017). Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH. Asian Pacific journal of cancer prevention: APJCP, 18(1), 17–21. https://doi.org/10.22034/APJCP.2017.18.1.17
Barrett, E. S., & Sobolewski, M. (2014). Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role? Seminars in reproductive medicine, 32(3), 166–176. https://doi.org/10.1055/s-0034-1371088
Basu, B. R., Chowdhury, O., & Saha, S. K. (2018). Possible Link Between Stress-related Factors and Altered Body Composition in Women with Polycystic Ovarian Syndrome. Journal of human reproductive sciences, 11(1), 10–18. https://doi.org/10.4103/jhrs.JHRS_78_17
Buliman, A., Tataranu, L. G., Paun, D. L., Mirica, A., & Dumitrache, C. (2016). Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment. Journal of medicine and life, 9(1), 12–18.
Chavarro, J. E., Rich-Edwards, J. W., Rosner, B. A., & Willett, W. C. (2009). Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility. Epidemiology (Cambridge, Mass.), 20(3), 374–381. https://doi.org/10.1097/EDE.0b013e31819d68cc
Daka, B., Rosen, T., Jansson, P. A., Råstam, L., Larsson, C. A., & Lindblad, U. (2012). Inverse association between serum insulin and sex hormone-binding globulin in a population survey in Sweden. Endocrine connections, 2(1), 18–22. https://doi.org/10.1530/EC-12-0057
Dittrich, R., Kajaia, N., Cupisti, S., Hoffmann, I., Beckmann, M. W., & Mueller, A. (2009). Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. Reproductive biomedicine online, 19(3), 319–325. https://doi.org/10.1016/s1472-6483(10)60165-4
Fan, A.M. (2014). Chapter 64 – Biomarkers in toxicology, risk assessment and environmental chemical regulations. In Biomarkers in Toxicology (pp. 1057 – 1080). San Diego, CA. Academic Press. doi: https://doi.org/10.1016/B978-0-12-404630-6.600064-6
González F. (2012). Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids, 77(4), 300–305. https://doi.org/10.1016/j.steroids.2011.12.003
Guo, Y., Qi, Y., Yang, X., Zhao, L., Wen, S., Liu, Y., & Tang, L. (2016). Association between Polycystic Ovary Syndrome and Gut Microbiota. PloS one, 11(4), e0153196. https://doi.org/10.1371/journal.pone.0153196
Isabella, R., Raffone, E. CONCERN: Does ovary need D-chiro-inositol? J Ovarian Res 5, 14 (2012). https://doi.org/10.1186/1757-2215-5-14
Longo, V. D., & Mattson, M. P. (2014). Fasting: molecular mechanisms and clinical applications. Cell metabolism, 19(2), 181–192. https://doi.org/10.1016/j.cmet.2013.12.008
Najem, F., Elmehdawi, R., & Swalem, A. (2008). Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study. The Libyan journal of medicine, 3(2), 71–74. https://doi.org/10.4176/080122
Patel, S., Zhou, C., Rattan, S., & Flaws, J. A. (2015). Effects of Endocrine-Disrupting Chemicals on the Ovary. Biology of reproduction, 93(1), 20. https://doi.org/10.1095/biolreprod.115.130336
Patterson, R. E., Laughlin, G. A., LaCroix, A. Z., Hartman, S. J., Natarajan, L., Senger, C. M., Martínez, M. E., Villaseñor, A., Sears, D. D., Marinac, C. R., & Gallo, L. C. (2015). Intermittent Fasting and Human Metabolic Health. Journal of the Academy of Nutrition and Dietetics, 115(8), 1203–1212. https://doi.org/10.1016/j.jand.2015.02.018
Perry, G. S., Patil, S. P., & Presley-Cantrell, L. R. (2013). Raising awareness of sleep as a healthy behavior. Preventing chronic disease, 10, E133. https://doi.org/10.5888/pcd10.130081
Rosenfield, R. L., & Ehrmann, D. A. (2016). The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine reviews, 37(5), 467–520. https://doi.org/10.1210/er.2015-1104
Samsel, A., & Seneff, S. (2013). Glyphosate’s Suppression of Cytochrome P450 Enzymes and Amino Acid Biosynthesis by the Gut Microbiome: Pathways to Modern Diseases. Entropy, 15(12), 1416–1463. MDPI AG. Retrieved from http://dx.doi.org/10.3390/e15041416
Speiser P. W. (2015). Congenital Adrenal Hyperplasia. F1000Research, 4(F1000 Faculty Rev), 601. https://doi.org/10.12688/f1000research.6543.1
Swithers S. E. (2013). Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements. Trends in endocrinology and metabolism: TEM, 24(9), 431–441. https://doi.org/10.1016/j.tem.2013.05.005
The Endocrine Society. (2019, March 23). Improved PCOS symptoms correlate with gut bacterial composition. ScienceDaily. Retrieved April 4, 2020 from www.sciencedaily.com/releases/2019/03/190323145201.htm
Zhao, X., Jiang, Y., Xi, H., Chen, L., & Feng, X. (2020). Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review. Geburtshilfe und Frauenheilkunde, 80(2), 161–171. https://doi.org/10.1055/a-1081-2036
Monday: 9am - 5pm
Tuesday: 9am - 5pm
Wednesday: 9am - 5pm
Thursday: 9am - 5pm
By appointment only
***IN LIGHT OF COVID-19 OUR HOURS ARE TEMPORARILY TUESDAY - THURSDAY 9AM- 5PM
We are scheduling telemedicine visits as well.
Copyright 2021 The Fork Functional Medicine. All rights reserved. Website by Wink Digital.